C O R P O R A T E / M A N A G E M E N T B A C K G R O U N D E R

For Information Contact:
Joni Morford, Communicore
714/721-8081
jmorford@communicore.com


ADVANCED STERILIZATION PRODUCTS: A DIVISION OF JOHNSON & JOHNSON MEDICAL, INC.


In the mid-1880s, a new company called Johnson & Johnson introduced the first prefabricated, 
ready-to-use sterile surgical dressings for wound treatment.  This product, which led to a 
dramatic reduction in the threat of infection and disease, marked the beginning of Johnson & 
Johnson's subsequent efforts to develop products for infection control, including the well-known 
BAND-AID* Brand Adhesive Bandage and the first industrial autoclave for sterilization.

*Trademark

In 1980, two Texas-based Johnson & Johnson companies (Arbrook and Surgikos) merged to 
become Surgikos, Inc.  Tralance Addy, Ph.D., an expert in innovation and technology 
development, was recruited to establish an applied research organization at Surgikos.  His 
research and development team focused on the long-range exploration and development of 
innovative technologies for medical and surgical instrument decontamination and sterilization.  
The group developed a unique low-temperature hydrogen peroxide gas plasma technology that 
became the basis for the STERRAD¨ Sterilization System.  The team filed the first patent 
application for the system in 1985.

The active commercialization phase for the venture began in 1986.  In late 1987, the venture 
became an independent operating division of Surgikos, Inc., and was officially named Advanced 
Sterilization Products (ASP).  Addy was appointed General Manager of the division in 1988.  
When Surgikos and Johnson & Johnson's Patient Care company merged in 1990, ASP became a 
division of the new company, Johnson & Johnson Medical, Inc.

The STERRAD System was introduced in Germany and France in 1992 and in the United States 
in October 1993.  The System is now distributed through a direct sales, marketing, and support 
infrastructure in the United States and through Johnson & Johnson affiliates in many other 
countries worldwide.

ASP is led by a senior management team with wide experience in the development and 
commercialization of emerging healthcare technologies.


Management


Tralance O. Addy, Ph.D., President, ASP Worldwide

Tralance Addy is responsible for ASP business growth and profitability worldwide.  Addy, who 
joined Johnson & Johnson in 1980, headed the team that developed and commercialized the first 
STERRAD System.  Prior to joining Johnson & Johnson, he held a number of leadership positions 
in technology development at Scott Paper.  Addy earned his B.A. and B.S. from Swarthmore 
College and his M.S. and Ph.D. from the University of Massachusetts, and he completed the 
Advanced Management Program at Harvard Business School.  He holds several patents in the areas 
of medical nonwoven materials and sterilization technology, and he has written and presented a 
number of lectures on the application of low-temperature plasma to instrument sterilization.


RenŽ Gfeller, Vice President and General Manager

RenŽ Gfeller is responsible for ASP's U.S. business, which focuses on the development and 
marketing of innovative sterilization systems and related products.  Gfeller relocated to the 
United States in 1995 from Germany, where he served as managing director of Johnson & 
Johnson Medical GmbH.  He joined Johnson & Johnson in 1973 as product manager of patient 
care in Switzerland.  Gfeller earned degrees in commerce and economics in Zurich, Switzerland.


Ted H. Toch, Vice President, Sales

Ted Toch joined ASP in 1993 to develop the marketing, sales, and clinical education team that 
introduced the STERRAD System in the United States.  Under his guidance, ASP achieved a 
significant market share within the first two years.  Prior to joining ASP, Toch served in various 
marketing management positions at Nellcor, Air-Shields, Telectronics Pacing Systems, and 
Xomed.  He earned his B.S.E.E. from New York Institute of Technology and his M.B.A. from 
Loyola University, and he has completed advanced executive programs at Harvard and Duke 
universities.  


John Onopchenko, Vice President, Marketing

John Onopchenko is responsible for domestic marketing functions, including leadership in 
the development of marketing strategy and new product development direction.  
Onopchenko has 15 years of marketing, sales, and sales management experience in the 
medical device industry.  Most recently, he served as vice president of marketing at Cardiac 
Mariners, a medical imaging company.  Previously, he served as the global marketing 
manager-high field magnetic resonance at General Electric Medical Systems.  Onopchenko 
earned his B.S. from Ursinus College and his M.B.A. from the University of Chicago.


David M. Paterson, Vice President, Finance

David Paterson is responsible for managing ASP's financial systems globally.  Paterson spent 
more than 23 years with Johnson & Johnson's Canadian divisions.  He has worked in various 
marketing and finance management positions, and was responsible for the development of ASP 
business in Canada.  Prior to joining Johnson & Johnson, he worked at Philips Electronics and 
Gulf Oil in key financial positions.  Paterson graduated from Agincourt Collegiate Institute in 
Ontario, Canada, and he received his Certified Management Accountants designation (C.M.A.) 
from the Society of Management Accountants.


Andrew L. Lux, Ph.D., Vice President, Operations

Andrew Lux is responsible for worldwide operations, including all product manufacturing, 
sourcing, logistics, and manufacturing engineering.  Prior to joining ASP, Lux served as vice 
president of operations at Diasonics, a medical electronics company.  He earned his B.S. from 
Cleveland State University, M.S. and Ph.D. from M.I.T., and M.B.A. from Case Western Reserve 
University.  Lux holds patents in metal purification processing and alternative materials for X-ray 
tubes, and he has published articles in the field of materials science and processing.


Robert M. Spencer, Director, Technology Development

Robert Spencer headed the team of engineers that developed the first STERRAD Sterilizer.  In 
recognition of this contribution, in 1994 he was awarded the Johnson Medal, Johnson & 
Johnson's highest honor, for excellence in research and development.  Spencer joined Johnson & 
Johnson in 1986 after working a number of years in the management and design of new products 
for alternative energy generation and semiconductor equipment.  Spencer earned his B.S. degree 
in chemical engineering from the California Institute of Technology.  He holds patents in coal 
gasification, solar energy, photovoltaics, and sterilization equipment and processes.


Paul T. Jacobs, Ph.D., Senior Research Fellow 

Paul Jacobs is responsible for several aspects of research, including research supervision, patent 
application, and scientific publications and presentations.  He was a member of the team that 
developed the first STERRAD Sterilizer.  In recognition of this contribution, in 1994 Jacobs was 
also awarded the Johnson Medal.  He has been active in research and development at Johnson & 
Johnson since he joined the company in 1976 as a senior research chemist.  Jacobs earned his 
B.S., M.S., and Ph.D. from the University of Idaho and completed a postdoctoral fellowship at 
Montana State University.  He holds several patents, has written articles, and has presented a 
number of lectures on the subject of medical instrument sterilization.


Patricia A. Antonoplos, Ph.D., Director, Research

Patricia Antonoplos is responsible for development and after sales support projects for the 
STERRAD System.  Antonoplos joined ASP in 1992, after serving in various development 
positions in the Diagnostic Systems Group and Electro-products Group at Beckman Instruments.  
She earned her B.S. degree from the University of Pittsburgh, M.S. and Ph.D. from Northwestern 
University, and M.B.A. from the University of California at Los Angeles.  Antonoplos holds 
several patents, and she has published articles and given presentations on a range of topics.


End of document.